Abstract
Caspase activation has been frequently viewed as synonymous with apoptotic cell death; however, caspases can also contribute to processes that do not culminate in cell demise. Moreover, inhibition of caspases can have cytoprotective effects. In a number of different models, caspase inhibition does not maintain cellular viability and instead shifts the morphology of death from apoptosis to nonapoptotic pathways. Here, we explore the contribution of caspases to cell death, either as upstream signals or as downstream effectors contributing to apoptotic morphology, as well as alternative strategies for cell death inhibition. Such alternative strategies may either target catabolic hydrolases or be aimed at preventing mitochondrial membrane permeabilization and its upstream triggers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Horvitz, H.R. Worms, life, and death. ChemBioChem 4, 697–711 (2003).
Hay, B.A., Huh, J.R. & Guo, M. The genetics of cell death: approaches, insights and opportunities in Drosophila. Nat. Rev. Genet. 5, 911–922 (2004).
Abraham, M.C. & Shaham, S. Death without caspases, caspases without death. Trends Cell Biol. 14, 184–193 (2004).
Boyce, M., Degterev, A. & Yuan, J. Caspases: an ancient cellular sword of Damocles. Cell Death Differ. 11, 29–37 (2004).
Golstein, P., Aubry, L. & Levraud, J.P. Cell-death alternative model organisms: why and which? Nat. Rev. Mol. Cell Biol. 4, 798–807 (2003).
Martin, S.J. & Green, D.R. Protease activation during apoptosis: death by a thousand cuts? Cell 82, 349–352 (1995).
Garrido, C. & Kroemer, G. Life's smile, death's grin: vital functions of apoptosis-executing proteins. Curr. Opin. Cell Biol. 16, 639–646 (2004).
Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561–574 (2004).
Tinel, A. & Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304, 843–846 (2004).
Krammer, P.H. CD95's deadly mission in the immune system. Nature 407, 789–795 (2000).
Jiang, X. & Wang, X. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73, 87–106 (2004).
Zhivotovsky, B. Caspases: the enzymes of death. Essays Biochem. 39, 25–40 (2003).
Danial, N.N. & Korsmeyer, S. Cell death: critical control points. Cell 116, 205–219 (2004).
Enoksson, M. et al. Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J. Biol. Chem. 279, 49575–49578 (2004).
Kroemer, G. et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell death. Cell Death Differ. (in the press) (2005).
Fischer, U., Janicke, R.U. & Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10, 76–100 (2003).
Xiang, J., Chao, D.T. & Korsmeyer, S.J. Bax-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl Acad. Sci. USA 93, 14559–14563 (1996).
Carter, B.Z. et al. Caspase-independent cell death in AML: caspase-inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood 102, 4179–4186 (2003).
Kanzawa, T. et al. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24, 980–991 (2005).
Nicholson, D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000).
Methot, N. et al. Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics. J. Exp. Med. 199, 199–207 (2004).
Saleh, M. et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75–79 (2004).
Chun, H.J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395–399 (2002).
Kang, T.B. et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173, 2976–2984 (2004).
Sordet, O. et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100, 4446–4453 (2002).
Miura, M. et al. A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J. Clin. Invest. 114, 1704–1713 (2004).
Fernando, P., Kelly, J.F., Balazsi, K., Slack, R.S. & Megeney, L.A. Caspase 3 activity is required for skeletal muscle differentiation. Proc. Natl Acad. Sci. USA 99, 11025–11030 (2002).
Black, S. et al. Syncytial fusion of human trophoblast depends on caspase 8. Cell Death Differ. 11, 90–98 (2004).
McLaughlin, B. The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling. Apoptosis 9, 111–121 (2004).
Cross, T. et al. PKC-delta is an apoptotic lamin kinase. Oncogene 19, 2331–2337 (2000).
Desagher, S. et al. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 8, 601–611 (2001).
McLaughlin, B. et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl Acad. Sci. USA 100, 715–720 (2003).
Garnier, P., Ying, W. & Swanson, R.A. Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J. Neurosci. 23, 7967–7973 (2003).
Yang, J.Y. et al. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol. Cell. Biol. 24, 10425–10436 (2004).
Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C. & Brouckaert, P. Caspase inhibition causes hyperacute TNF shock via oxidative stress and PLA2. Nat. Immunol. 4, 387–393 (2003).
Vercammen, D. et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477–1485 (1998).
Foghsgaard, L. et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999–1010 (2001).
Kroemer, G. & Reed, J.C. Mitochondrial control of cell death. Nat. Med. 6, 513–519 (2000).
Green, D.R. & Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626–629 (2004).
Chipuk, J.E. & Green, D.R. Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6, 268–275 (2005).
Susin, S.A. et al. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192, 571–579 (2000).
Jaattela, M. & Tschopp, J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4, 416–423 (2003).
Yu, L. et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500–1502 (2004).
Shimizu, S. et al. A role of Bcl-2 family of proteins in non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 6, 1221–1228 (2004).
Hirsch, T. et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573–1582 (1997).
Glazner, G.W., Chan, S.L., Lu, C. & Mattson, M.P. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641–3649 (2000).
Lassus, P., Opitz-Araya, X. & Lazebnik, Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352–1354 (2002).
Vanden Berghe, T. et al. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J. Biol. Chem. 279, 7925–7933 (2004).
Zhu, C. et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J. Neurochem. 86, 306–317 (2003).
Hisatomi, T. et al. Relocalization of apoptosis-inducing factor in photoreceptor apoptosis induced by retinal detachment in vivo. Am. J. Pathol. 158, 1271–1278 (2001).
Nussbaum, A.K. & Whitton, J.L. The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor. J. Immunol. 173, 6611–6618 (2004).
Fukuda, H. et al. Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition. Cell Death Differ. 11, 1166–1178 (2004).
Higuchi, M. et al. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280, 15229–15237 (2005).
Baines, C.P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).
Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652–658 (2005).
Strasser, A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5, 189–200 (2005).
Kuwana, T. et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331–342 (2002).
Kuwana, T. et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell 17, 525–535 (2005).
Chen, L. et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17, 393–403 (2005).
Mattson, M.P. & Kroemer, G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9, 196–205 (2003).
Stavrovskaya, I.G. et al. Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology. J. Exp. Med. 200, 211–222 (2004).
Fischer, S.F. et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J. Exp. Med. 200, 905–916 (2004).
Muntener, K., Zwicky, R., Csucs, G., Rohrer, J. & Baici, A. Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death. J. Biol. Chem. 279, 41012–41017 (2004).
Guicciardi, M.E., Miyoshi, H., Bronk, S.F. & Gores, G.J. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am. J. Pathol. 159, 2045–2054 (2001).
Canbay, A. et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 112, 152–159 (2003).
Liu, N. et al. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5, 919–926 (2004).
Benchoua, A., Braudeau, J., Reis, A., Couriaud, C. & Onteniente, B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 24, 1272–1279 (2004).
Takano, J. et al. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: Evidence from calpastatin-mutant mice. J. Biol. Chem. 280, 16175–16184 (2005).
Saelens, X. et al. Toxic proteins released from mitochondria in cell death. Oncogene 23, 2861–2874 (2004).
Cande, C. et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23, 1514–1521 (2004).
Wissing, S. et al. An AIF orthologue regulates apoptosis in yeast. J. Cell Biol. 166, 969–974 (2004).
Parrish, J.Z. & Xue, D. Functional genomic analysis of apoptotic DNA degradation in C. elegans. Mol. Cell 11, 987–996 (2003).
Joza, N. et al. Essential role of the mitochondrial apoptosis inducing factor in programmed cell death. Nature 410, 549–554 (2001).
Cheung, E.C. et al. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J. Neurosci. 25, 1324–1334 (2005).
Cilenti, L. et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 279, 50295–50301 (2004).
Trencia, A. et al. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J. Biol. Chem. 279, 46566–46572 (2004).
Gupta, S. et al. The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity. J. Biol. Chem. 279, 45844–45854 (2004).
Cilenti, L. et al. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am. J. Physiol. Renal Physiol. 288, F371–F379 (2005).
Liu, H.R. et al. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 111, 90–96 (2005).
Rustin, P. The use of antioxidants in Friedreich's ataxia treatment. Expert Opin. Investig. Drugs 12, 569–575 (2003).
Liu, X., Van Vleet, T. & Schnellmann, R.G. The role of calpain in oncotic cell death. Annu. Rev. Pharmacol. Toxicol. 44, 349–370 (2004).
Cregan, S.P. et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158, 507–517 (2002).
Wang, H. et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24, 10963–10973 (2004).
Matsumori, Y. et al. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab. 2 March 2005 (10.1038/sj.jcbfm.9600080).
Acknowledgements
G.K. is supported by Ligue Nationale contre le cancer, European Union (Active p53, Impaled, RIGHT, Trans-Death), Canceropole Ile-de-France, and French Ministry of Science. S.J.M. is supported by a Principal Investigator Award from Science Foundation Ireland.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kroemer, G., Martin, S. Caspase-independent cell death. Nat Med 11, 725–730 (2005). https://doi.org/10.1038/nm1263
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1263
This article is cited by
-
Chaga mushroom extract suppresses oral cancer cell growth via inhibition of energy metabolism
Scientific Reports (2024)
-
Induction of the mitochondrial pathway of apoptosis by enrofloxacin in the context of the safety issue of its use in poultry
Apoptosis (2024)
-
Swimming prevents cell death of chondrocytes via PI3K/AKT pathway in an experimental model
Journal of Orthopaedic Surgery and Research (2023)
-
ARHGAP–RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer
Oncogene (2022)
-
SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
Cellular Oncology (2022)